Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.
BACKGROUND
Although overexpression of nitric oxide synthases (NOSs) has been found associated with prostate diseases, the underlying mechanisms for NOS-related prostatic diseases remain unclear. One proposed mechanism is related to the S-nitrosylation of key regulatory proteins in cell-signaling pathways due to elevated levels of NO in the prostate. Thus, our primary objective was to identify S-nitrosylated targets in an immortalized normal prostate epithelial cell line, NPrEC.


RESULTS
We treated NPrEC with nitroso-cysteine and used the biotin switch technique followed by gel-based separation and mass spectrometry protein identification (using the LTQ-Orbitrap) to discover S-nitrosylated (SNO) proteins in the treated cells. In parallel, we adapted a peptide pull-down methodology to locate the site(s) of S-nitrosylation on the protein SNO targets identified by the first technique. This combined approach identified 116 SNO proteins and determined the sites of modification for 82 of them. Over 60% of these proteins belong to four functional groups: cell structure/cell motility/protein trafficking, protein folding/protein response/protein assembly, mRNA splicing/processing/transcriptional regulation, and metabolism. Western blot analysis validated a subset of targets related to disease development (proliferating cell nuclear antigen, maspin, integrin beta4, alpha-catenin, karyopherin [importin] beta1, and elongation factor 1A1). We analyzed the SNO sequences for their primary and secondary structures, solvent accessibility, and three-dimensional structural context. We found that about 80% of the SNO sites that can be mapped into resolved structures are buried, of which approximately half have charged amino acids in their three-dimensional neighborhood, and the other half residing within primarily hydrophobic pockets.


CONCLUSIONS
We here identified 116 potential SNO targets and mapped their putative SNO sites in NPrEC. Elucidation of how this post-translational modification alters the function of these proteins should shed light on the role of NO in prostate pathologies. To our knowledge, this is the first report identifying SNO targets in prostate epithelial cells.
Lam
Ying Wai
YW
Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.
Yuan
Yong
Y
Isaac
Jared
J
Babu
C V Suresh
CV
Meller
Jarek
J
Ho
Shuk-Mei
SM
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D001665:Binding Sites; D019921:Biotinylation; D015153:Blotting, Western; D002460:Cell Line; D045744:Cell Line, Tumor; D003460:Crystallization; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009569:Nitric Oxide / Q000378:metabolism; D015538:Nitrosation; D010449:Peptide Mapping / Q000379:methods; D011467:Prostate / Q000166:cytology / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000737:chemistry / Q000145:classification / Q000378:metabolism*; D040901:Proteomics / Q000379:methods
D011506:Proteins; D009569:Nitric Oxide